Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent
August 31, 2021 07:00 ET
|
MediPharm Labs Corp.
McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter...
MediPharm Labs Australia Receives Government Grant to Assist with International Expansion
August 19, 2021 07:00 ET
|
MediPharm Labs Corp.
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s Manufacturing Modernisation program aimed at supporting manufacturers scaling their...
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil
August 18, 2021 07:15 ET
|
MediPharm Labs Corp.
Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits issued from Health Canada. Initial deliveries will be under the...
Copperstate Farms Expands Cultivation Headquarters with New Hydrocarbon Lab
August 17, 2021 12:00 ET
|
Copperstate Farms
PHOENIX, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Copperstate Farms Management, LLC, a vertically integrated cannabis company based in Arizona, today announced the completion of a new hydrocarbon lab at...
MediPharm Reports Second Quarter 2021 Results and Advances Pharmaceutical Strategy; Announces new Board Chair
August 16, 2021 07:15 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, Aug. 16, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in research-driven...
MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results
August 10, 2021 07:00 ET
|
MediPharm Labs Corp.
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in research-driven...
MediPharm Labs Achieves Major Pharmaceutical Manufacturing Milestone: Receives Canadian GMP Pharmaceutical Drug Establishment Licence
July 14, 2021 07:00 ET
|
MediPharm Labs Corp.
Health Canada Drug Establishment Licence allows MediPharm Labs to conduct pharmaceutical manufacturing and sale of Active Pharmaceutical Ingredients and Pharmaceutical Drug ProductsMakes MediPharm...
MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
June 21, 2021 07:00 ET
|
MediPharm Labs Corp.
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple...
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
April 09, 2021 09:02 ET
|
WeedMD Rx Inc.
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis,...
WeedMD’s Starseed Medicinal Announces the Release of Strain-Specific Products for PAX® ERA® Vaporizer
February 25, 2021 08:03 ET
|
WeedMD Rx Inc.
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...